Highlights • SARS-CoV-2 infection after the first BNT162b2 dose does not boost antibody response. • A postponed second dose induced antibody titres similar to those in naïve vaccinees. • We advise a second vaccine dose for individuals infected early after the first dose.
Antibody response in individuals infected with SARS-CoV-2 early after the first dose of the BNT162b2 mRNA vaccine: SARS-CoV-2 infection early after the first vaccine dose
Riccetti, Silvia;Sinigaglia, Alessandro;Barzon, Luisa
2021
Abstract
Highlights • SARS-CoV-2 infection after the first BNT162b2 dose does not boost antibody response. • A postponed second dose induced antibody titres similar to those in naïve vaccinees. • We advise a second vaccine dose for individuals infected early after the first dose.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gobbi_manuscript text_JI.pdf
accesso aperto
Descrizione: Articolo con tabella e figura
Tipologia:
Preprint (submitted version)
Licenza:
Creative commons
Dimensione
147.44 kB
Formato
Adobe PDF
|
147.44 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
